NCT03425279 — Undifferentiated Pleomorphic Sarcoma trial site landscape

Public-registry site landscape for NCT03425279, a Undifferentiated Pleomorphic Sarcoma study sponsored by BioAtla, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.

Trial	NCT03425279 (registry record)
Sponsor	BioAtla, Inc.
Condition(s)	Undifferentiated Pleomorphic Sarcoma; Myxofibrosarcoma
Phase	PHASE1 / PHASE2
Listed sites	40
Site countries	United States, Hong Kong, Taiwan

Free site-risk snapshot for this trial

Eichor generates a preliminary site-risk snapshot for NCT03425279 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →

Planning or rescuing a trial? Eichor generates evidence-linked site-risk reports from public data in minutes. Get a free preliminary snapshot →
Launch offer through July 31: first full site unlock free — one per company.